Here's why Coca-Cola Amatil Ltd got slammed today

Coca-Cola Amatil Ltd (ASX:CCL) continues to test investors' patience, but is it worth the wait?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of the embattled beverage giant Coca-Cola Amatil Ltd (ASX: CCL) have been hammered again today, trading 28 cents or 3.1% lower at $8.82 per unit. The fall comes after the company released an update regarding its operations yesterday, in which it revealed 260 employees would be shed as part of its overall cost-cutting drive.

So What: When the company last updated the market on the results of its strategic review, the results were well received with the company outlining plans to cut up to $100 million in annual costs and to drive growth in Indonesia and Australia.

While the Indonesian business (which has long been touted as the company's enormous growth prospect) has reportedly experienced strong volume growth and improvements in market share, it also reported that "pricing and profitability remain under pressure due to the level of competition and ongoing cost pressures".

Investors may have been further disappointed by the continuation of "challenging" conditions in the Australian market. Ms Alison Watkins, the company's Managing Director, admitted that "we have not yet seen the anticipated improvements in the grocery channel and operational accounts". She did add that a better performance is expected in the second half, but investors may have chosen not to get their hopes up.

Now What: Admittedly, it is tough playing the waiting game with Coca-Cola Amatil. As a shareholder myself, the company's slow turnaround has certainly tested my patience.

However, I am still a firm believer in the company's long-term potential. While its recovery might take a while, Coca-Cola Amatil still boasts a network of some of the world's most recognisable and popular brands which I believe will prevail in the long term. With a strong balance sheet, Coca-Cola Amatil should be able to maintain strong dividend payments (particularly with the company still forecasting a return to earnings growth in the near future), which will make the wait more bearable.

As attractive as Coca-Cola Amatil is at these prices, there's a stock that our top analyst, Scott Phillips, believes is an even greater buy in 2015…

Motley Fool contributor Ryan Newman owns shares in Coca-Cola Amatil Ltd.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »